HARBOUR HCAB+ Trademark

Trademark Overview


On Tuesday, July 19, 2022, a trademark application was filed for HARBOUR HCAB+ with the United States Patent and Trademark Office. The USPTO has given the HARBOUR HCAB+ trademark a serial number of 97510185. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, August 24, 2023. This trademark is owned by Harbour Antibodies U.S., Inc.. The HARBOUR HCAB+ trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Diagnostic preparations for medical purposes; Drug delivery agents in the form of powders, tablets, capsules, solutions, cells and nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Tumor suppressing agents; Pharmaceutical products for the prevention and treatment of cancer; Medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Chemical p...

Technical research in the field of pharmaceutical studies; Research and development of new products for others; Scientific investigations for medical purposes; Development of pharmaceutical preparations and medicines; Medical laboratory services; Scientific research in the nature of conducting clinical trials for others; medical research; biological research; Biochemical research and analysis; Testing of pharmaceuticals
harbour hcab+

General Information


Serial Number97510185
Word MarkHARBOUR HCAB+
Filing DateTuesday, July 19, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, August 24, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDiagnostic preparations for medical purposes; Drug delivery agents in the form of powders, tablets, capsules, solutions, cells and nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Tumor suppressing agents; Pharmaceutical products for the prevention and treatment of cancer; Medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biological preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biochemical medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor
Goods and ServicesTechnical research in the field of pharmaceutical studies; Research and development of new products for others; Scientific investigations for medical purposes; Development of pharmaceutical preparations and medicines; Medical laboratory services; Scientific research in the nature of conducting clinical trials for others; medical research; biological research; Biochemical research and analysis; Testing of pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 9, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 9, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHarbour Antibodies U.S., Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNEWTON, MA 02458

Trademark Events


Event DateEvent Description
Thursday, August 24, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, August 24, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, August 24, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, May 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 10, 2023NON-FINAL ACTION E-MAILED
Wednesday, May 10, 2023NON-FINAL ACTION WRITTEN
Wednesday, May 3, 2023ASSIGNED TO EXAMINER
Tuesday, August 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 22, 2022NEW APPLICATION ENTERED